Between digital therapeutics, HCP portals, and patient support communications, pharma companies are investing a significant portion of their revenues on digital products.
Innovation is of no worth if it doesn’t provide better outcomes for patients. Indeed, such advancements should hold as centre the amelioration of the overall patient experience.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.